Insider · CIK 0001905102
Kenny Myers
Files at MGRX (MANGOCEUTICALS, INC.). First filing -, latest -.
In brief
Kenny Myers files SEC Form 4 as director at MGRX (MANGOCEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kenny Myers has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | MGRX MANGOCEUTICALS, INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 136,667 | Sep 12, 2025 |
| Apr 10, 2025 | MGRX MANGOCEUTICALS, INC. | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 36,667 | Apr 11, 2025 |
Questions about Kenny Myers
Answered from the filings on this page, as of the latest one.
Is Kenny Myers buying or selling?
Kenny Myers has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kenny Myers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kenny Myers has 0.
Where does Kenny Myers file Form 4?
Kenny Myers has filed Form 4 at MGRX (MANGOCEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.